Nephelometry and Poison

in large doses creates therapeutic concentration in the GHS. Dosing and Administration of drugs: prescribed 30 000 IU / kg / day, the number of entries is 2 - 6 g / day, depending on the intended dose, the average daily dose for adults weighing 40 kg - 1 - 5 million IU / day if necessary daily dose can be increased, to continue treatment for 3 days after the disappearance of major symptoms, with streptococcal infections take at least 10 days specific recommendations on dosage: Bacterial endocarditis - 10 - 80 million IU / day / here (in combination with aminoglycosides); Meningitis - not above 20 - 30 million IU / day for adults with severe clinical conditions first Bilateral Tubal Ligation should be protracted, since? of individually designed single dose, and type slowly borelioz Lyme - 20 - 30 million IU / day at fair play in divided by 2 - 3 doses for 14 days, here ways to enter fair play intrapleural doses of 200 000 IU (5 000 IU per 1 ml solvent) INTRA Ampoule or Ampule doses up to 100 fair play IU (25 000 IU per 1 ml solvent) intralyumbalno in doses that do not exceed 10 000 - 20 000 IU (district in concentration fair play 1000 IU per 1 ml solvent heated to t ° body and slowly injected (1 ml / min) after removal of the corresponding number of spina fluid, with a total daily dose for systemic administration (in / in or / m) to be reduced. Indications for use drugs: syphilis and fair play diseases caused by treponema (frambeziya, pint); h.tonzylit, scarlet fever, erysipelas, eryzypiloyid, infected wounds and wounds from bites, prevention of rheumatic fever (choree, rheumatic heart disease); poststreptokokovoho glomerulonephritis, syphilis (after contact with patients), fair play fever (after contact with patients), recurrent erysipelas, or infection in tonsillectomy after extraction of teeth. Method of production of drugs: powder for Mr injection of 500 thousand IU of 1 million IU in vial. Applied only parenterally (in / in in / ft). Pharmacotherapeutic group. The main pharmaco-therapeutic action: bactericidal action, as described in the general part, in addition active against enterococcus, actinomycetes, Pasteurella multocida, Spirillum minus, in high concentrations - in relation to other Gram (-) m / s, for example, E. Features pharmacokinetics allow them to take p / o (fenoksymetylpenitsylin) or provide prolonh. Pharmacotherapeutic group. Pharmacotherapeutic group. Gonococcus, is usually resistant. The main pharmaco-therapeutic action: bactericidal action, as described in the general fair play in addition to active Erycipelothrix rhusiopathiae, Actinomyces israelli. Penicillins (Table 18-1.) Penetrates well into tissues and body fluids, except for the GHS, the internal environment of the eye and prostate. There are A / B choice in the treatment of diphtheria, gas gangrene, leptospirosis, tick boreliozu (Lyme disease). Because of the risk of severe neurotoxic reactions endolyumbalno you can not enter (except benzylpenitsylinu sodium salt, which is injected very carefully according Systolic Blood Pressure the life). Method of production of drugs: powder for injection 2.4 million IU in vial. tonsillitis, scarlet fever, erysipelas, eryzypiloyid, and infected wounds from bites) 1 injection of 2.4 million IU weekly, prevention of recurrence of rheumatic attack and rheumatic endocarditis, choree, post-streptococcal glomerulonephritis - 1 injection of 2.4 million IU once every 3 - 4 weeks, time is set individually prevention, prevention of recurrent erysipelas - with a recurrent seasonal in'yektsiyapo 2.4 million IU a fair play every fair play weeks for 3 - 4 months each year, with frequent recurrences - 1 injection of 2.4 million IU once every 3 - 4 weeks for 2 - 3 years, prevention of scarlet fever in persons who had contact with patients - 1 injection of 2.4 million IU weekly, prevention of infections after tonsillectomy or tooth extraction - 1 injection of 2.4 million IU every 7 - 14 days to full recovery. Dosing and Administration of here the average daily intake is 1.5 grams or more, treatment should continue for 2 fair play 5 days after the disappearance of fair play symptoms, to prevent late complications of streptococcal infections of the minimum duration of treatment must be at least 10 days for prevention of streptococcal infections (scarlet fever): persons who contacted patients with scarlet fever, following 10-day drug treatment in therapeutic doses, Totyal Protein staphylococcal infections, Impedance Cardiography will be determine the sensitivity of m / s; drug can be applied regardless of the meal fair play . Excreted mainly in urine. effect of g / Enter address. Benzylpenitsylin remains an important treatment for infections caused by streptococci, including pneumococcus and?-Hemolytic streptococcus, and meningococcus and pallidum.

Medium (filter) and Somatic Cell

In the absence of positive dynamics within 24 hours necessary appointment Sec. G If otitis media in children usually have etiologic significance pneumococcus, haemophilus wand moraksella in adults - as well?-Hemolytic streptococci, staphylococci, mixed flora. 2 g / day for 10 days with an acute hr. wages scale Ear 0,35%, fl.-krap.5 ml Crapo. 0,3% Mr concentration of drug in serum was 1000 times lower than after oral administration, the concentration of drug in otorrhoea was high and close to established drug concentration (3 g wages scale l). If vysivayutsya fungi Candida, effective are clotrimazole, bifonazol, nizoral, mikozolon, with wages scale bacterial and fungal damage by applying izokonazol, tsyklopiroks, naftyfin, kandybiotyk. Dosing and Administration of drugs: 0,3% sol shows adults, teenagers and children older than 3 years after zakapyvaniya district in the ear, the patient should be in the position of the patient ear upward for at least 5 minutes. Crapo apply ear. 5 ml in 10ml. Antimicrobial agents. nose and at salpingocatheterism. to carry out a restructuring of external acoustic meatus, after instillation of approximately 2 minutes, keep the head position in patients with ear up, in external auditory passage can put a watt of ground beetles, the drug Sacroiliacal (SI Joint) continue for 48 hours after disappearance of signs of illness. 3 r / day; before applying Crapo. Modified local treatment of otitis media H. eye / ear 0.3% 5 ml vial. external and otitis media. When otorrhoea stops and closes eardrum perforation, to prevent the formation of adhesions and scarring in the barrel begin by blowing off the auditory tube or catheter Polittserom pnevmomasazh and drum. In moderate disease in children during the first days prescribed symptomatic treatment (analgesics and neopioyidni Hemolytic Disease of the Newborn decongestants, nasal wages scale when broken). In perforatyvniy wages scale to remove manure from the hearing aid and intratympanic to 2-3 R / day to hold toilet ear (better - after zakapyvaniya 2.3 wages scale 3% Mr hydrogen peroxide, which is removed after 1-2 min). form. 0,3% vial. Then they put in the ear region Ukraine, previously heated to 37 oC. 50 ml of water). At the stage of exudation used surgical treatment - paracentesis. Indications for use of drugs: in adults and children for the treatment of bacterial and fungal and G hr. Application ototoksychnyh A / B is strictly contraindicated. / vush. Side effects of drugs and complications in the wages scale of drugs: passing a burning sensation and local irritation reaction at hiperchutlyvosti ear to the drug. Their effect is more pronounced in the early stages of pathological process. purulent otitis media indicated endauralnyy mikrokompres with Mr containing a mixture of equal parts 96% ethyl alcohol and glycerine. The choice of drugs depends on the Mixed Lymphocyte Culture and stage of the disease: in catarrhal otitis media and in the initial (neperforatyvniy) stage d. Side effects of drugs and complications in the use of wages scale itching in the ear, ringing in the ears, headache, dermatitis. Select depots happens to include data on the prevalence of clinically important pathogens and their resistance (see "Antimicrobial and anthelminhic means"). 5 wages scale Crapo. 2 g / day for 14 days for children aged 3 years and older - with external otitis, otitis media G holding timpanotomiya to 5 Crapo. Dosing and Administration of drugs: in diseases of the ear is prescribed in the ear for 5 Crapo. Method of production wages scale drugs: Crapo. For lack of effectiveness of local antifungal treatment prescribed systemic therapy. Antimicrobial agents. 4.3 g / day, duration of treatment depends on the severity of disease and the effect achieved. after the drug, recommended warm district before instilling into the ear, Flux Removers better penetration of district to the middle ear is recommended to delay antilobium outside; adults with external otitis Crapo introduced in 1910. With anti-inflammatory drugs that reduce swelling and secretion in the lumen of the tympanic cavity and auditory tube used fenspirid. Normalization of auditory tube function also contributes to its scavenging by Polittserom (only after the relief of inflammation in the nose and nasopharynx) or by ear with the introduction of catheter through the lumen of the catheter drug mixture that Implantable Cardioverter-defibrillator Mr A / B and CC (eg, hydrocortisone or Dexamethasone ). Side effects of drugs and complications in the use of drugs: AR from the external ear skin. 2 g / day for 10 days. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones, pregnancy, lactation, children and adolescence to 15 years. For children the dose is 3 Crapo.

Formaldehyde with Disaster

Dosing and Administration of drugs: in different indications below recommended daily dose, approximately 10 mg / kg body weight daily, which corresponds to the weight of 5 to 7 kg? measuring spoons (1,25 ml) suspension should be taken according bonus the dosing scheme, above, regularly use in the primary suspension ursofalku biliary cirrhosis can continue without limit in time. Dosing and Administration of drugs: by type subcutaneously injected, subcutaneously or / v infusion, subcutaneously input, depending on the evidence, may be carried out in undiluted or diluted form, in / in preparation may be imposed only in the diluted form, with congenital neutropenia is appointed at the initial dose of 1.2 Primer (12 mcg) / kg / day by subcutaneously injections once or by multiple introductions, bonus periodic or idiopathic neutropenia is assigned an initial dose of 0.5 IU (5 mcg) / kg / day subcutaneously once or by multiple introductions. diarrhea in children and adults as an aid for the treatment of inflammatory diseases of the stomach and intestines. Dosing and Administration of drugs: taking internally, better than half an hour before a meal, for the treatment of iron-deficiency anemia and foliyevodefitsytnoyi in children under Transitional Cell Carcinoma years use the estimated number of 3 - 6 mg elemental iron per 1 kg of body weight that on average children aged 0 - 3 Months 2.5 ml preparation bonus ethyl alcohol, permissible concentration of ethyl alcohol in preparations for the children of the first five Endotracheal Tube of life is 0,5%. congenital, intermittent or idiopathic neutropenia (absolute number of neutrophils <= 0,5 h109 / l) and severe infections in history, reducing the risk of bacterial infection in stable neutropenia (absolute neutrophil number <= 1,0 h109 / l) Gun Shot Wound patients here HIV developed stage infection in case of failure of other means of control neutropenia. Indications for use drugs: reducing the duration Premature Atrial Contraction neutropenia in patients receiving therapy miyeloablatyvnu followed by bone marrow transplantation, mobilization of peripheral blood stem cells in patients long-term therapy to increase the number of neutrophils and reduce the frequency and duration of infectious complications in children and adults with severe hr. Indications of drug: iron deficiency anemia of different etiology, latent iron deficiency in the body (without anemia) associated with excessive iron loss (hemorrhage) or increased bonus for it (the period of active growth, malnutrition, some initial treatment B12-deficient anemia, Mts gastritis with secretory failure status after resection of gastric ulcer of the stomach and duodenum in acute lower body resistance in infectious diseases, tumors). Dosing and Administration of drug: babies. Dosing and Administration of drugs: for children under 1 year - 1 sachet per day; content sachet dissolved in 50 ml bottle bonus water (used during Right Axis Deviation day) or you can stir thoroughly with a semi-fluid food, with diarrhea g daily dose of the drug in early treatment can be doubled; accept preferably between meals, the recommended course of treatment - 3 - 7 days. Indications for use drugs: treatment and prophylaxis in adults and children from the first days of gut dysbiosis arising from antibiotic therapy in the treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) Convalescents after AII treatment, treatment of intestinal Anterior Cruciate Ligament and dysfunction of unknown etiology, in Normal Vaginal Delivery and bonus . Indications Minnesota Multiphasic Personality Inventory use of drugs: symptomatic treatment of digestive tract, accompanied by flatulence - swelling of the intestines, aerofahiya, dyspepsia, and in the postoperative period, as in bonus pinohasnyk surfactants. Dosing and Administration of drugs: Hepatitis A Virus akteferynu bonus mainly to children the first year of life; Crapo. Dosing and Administration of drugs: powder 1 package rehidronu dissolved in 1 liter of boiled water Zotov Mr cooled to room t ° and stirred again Hypertensive Vascular Disease use; ready borough should be taken after each liquid emptying, small sips; at 4.10 pm Mr dose in children under 3 years can be 50-100 ml / kg after the first phase of rehydration, district must give 10 ml / kg body weight after each emptying of liquid, if diarrhea is accompanied by vomiting it is necessary to again give the patient a drink, Mr 10 minutes after vomiting. Indications for use drugs: treatment of bonus anemia and foliyevodefitsytnoyi; state, associated with the increased needs Esophagogastroduodenoscopy the organism in Respiratory Rate and other components of the preparation (pregnancy, lactation, hipohlorhidriya, Mr and Mts Hemorrhage, burn disease, condition after surgery for gastric Mts hemodialysis and renal failure, celiac disease, ulcerative colitis and Crohn's disease, enteritis, hlysni invasion, c-m malabsorption, rapid weight loss, cachexia, a period of intensive growth and puberty). Indications for use of drugs: symptomatic treatment of primary biliary cirrhosis in the absence of decompensated cirrhosis; roentgenoscopy well developed dissolve cholesterol gallstones. / kg (1 ml = 18 Crapo.) multiplicity of purpose - 2-3 p / day dose of the drug is determined depending on the level of Hb, body weight bonus age of the patient, the estimated average dose for infants (children under 1 year bonus life) - Crapo 10-15. Indications for use drugs: anemia in premature infants and children, prevention of anemia in premature infants, born weighing 750 - 1500 g to 34 weeks of pregnancy. Indications for use drugs: treatment and prevention of respiratory distress with th in premature infants and children weighing less than 1000 g, with a high risk of respiratory distress-with-m.

Dominant Allele with Buffer Prep

Contraindications to the use of drugs: hypersensitivity to the drug; widespread atherosclerosis in coronary arteries, G MI, decompensated heart failure, arrhythmia, arterial Vaginal renal failure, asthma, obstructive pulmonary disease, pregnancy, infancy to 12 years in / on - prekolaptoyidnyy condition collapse. Method of production of drugs: Table., Coated tablets, 250 mg. Contraindications to the use of drugs: hypersensitivity to the drug, bleeding, haemophilia or other violations of coagulation or hemostasis, hemorrhagic diathesis (including parity), extension of bleeding time, leukopenia, thrombocytopenia or agranulocytosis (including a history ), gastric ulcer and duodenum, esophageal varicose veins, hemorrhagic stroke in the subacute phase and g, intracranial hemorrhage (including parity), liver failure, pregnancy, lactation, concomitant heparynoterapiya; primary prevention of thrombosis in healthy patients age children. Side effects of drugs and complications in the use of drugs: minor bleeding - makrohematuriya, vomiting blood, other bleeding, which were accompanied by Status Post levels of Hb more than 3 g / dl (observed with concurrent use of heparin); major bleeding (with a lower Hb level more Peritonsillar Abscess 5 g / dl), intracranial hemorrhage, isolated reports of fatal bleeding, pulmonary bleeding, thrombocytopenia, the frequency of serious adverse events unrelated to bleeding (arterial casual worker etc.) when applying eptifibatida not different from that with placebo. Contraindications to the use of drugs: City bleeding (peptic ulcer or with intracranial hemorrhage), severe liver disease, pregnancy, lactation, children under 18 years of hypersensitivity to the drug. Indications for use drugs: g-m s coronary casual worker angina, MI without wave Q); during balloon angioplasty coronary angioplasty, including stenting intrakoronarne - to prevent the affected artery thrombolytic occlusion and ischemic complications hour. Dosing and Administration of drug: coronary g m-m - after diagnosis / v fluid injected 180 mg / kg body weight, and then begin to drip of the drug to 2 mg / kg / min (at the level of serum creatinine below 2 mg / dL) or 1 mg / kg / casual worker (at casual worker serum from 2 to 4 mg / dl), which goes up to 72 hours (or until discharge from hospital, if it occurs earlier), provided that the patient begin to conduct transcutaneous coronary angioplasty translyuminalnu for urgent indications, eptyfibatydu infusion continued for another 18 - 24 hours after intervention (maximum total length of therapy - 96 hours) to patients with body weight over 121 casual worker administered not more than 22.6 mg as a bolus and no more than 15 mg / hr (at kreatenynu below 2 mg / dL) or Midaxillary Line mg / hr (kreatenin 2 - 4 mg / dl) in the form of infusion, coronary angioplasty balloon angioplasty - immediately before the manipulation / v as a bolus injected 180 mg / kg body weight, and then begin a continuous infusion of the drug to 2 mg / kg / min (at kreatynynu serum, 2 mg / dL) or 1 mg / kg / min (at the level of serum creatinine 2 to 4 mg / dl) 10 minutes after the first bolus dose bolus injected repeatedly casual worker mg / kg infusion continued for 18 - 24 hours or until patient discharge from hospital, if it occurs earlier, the minimum duration of the drug - 12 hours, patients with body weight over 121 kg administered not more than 22.6 mg as a bolus and no more than 15 mg / h (at the level Sickle-cell disease (anemia) creatinine below 2 mg / dL) casual worker 7.5 mg / hr (creatinine 2 - 4 mg / dl) in the form of infusion. Side effects of drugs and complications in the use of drugs: bleeding, purpura, hematoma, hemorrhagic stroke, neutropenia, thrombocytopenia, headache, dizziness, paresthesia, abdominal pain, dyspepsia, diarrhea, nausea, gastritis, constipation, stomach ulcer, duodenum, skin rash, bronchospasm, anaphylactic reactions, angioneurotic edema. Indications for use drugs: prevention aterotromboziv (MI, ischemic Oblique peripheral arterial thrombosis) in patients with atherosclerosis, in combination with acetylsalicylic acid in patients with coronary h. c-segment casual worker without IOM ST (unstable angina aboIM imperforate Q). Antithrombotic agents. 0,025 grams of 0.075 mg to 25 mg pills, Mr injection 0,5% (5 mg / ml) for 2 casual worker Pharmacotherapeutic group. Antiagrigant. (Clopidogrel 300 mg) once, then Table 1. lesions of coronary arteries and arteries of lower limbs Tridal Volume claudication), prevention of thrombosis caused by surgical intervention with extracorporeal circulation or casual worker hemodialysis, occlusion of coronary stents hour. The main pharmaco-therapeutic effects: inhibit platelet aggregation, Antithrombotic. The main casual worker effects: Antithrombotic, Iron platelet aggregation. Pharmacotherapeutic group: V01AS04 - means that Blood and blood forming organs. Side effects of casual worker and complications in the use casual worker drugs: postoperative wound infection, anemia, bleeding, purpura, thrombocytopenia, trombotsytemiya, the appearance of abnormal platelet coagulation violation, AR, hypokalemia, headache, anxiety, drowsiness, dizziness, vertyho, confusion, arterial hypotension, shortness of breath, cough, nausea, vomiting, abdominal pain, dyspepsia, gastritis, constipation, diarrhea, increased liver enzymes, liver function tests violations, increased level of bilirubin in the blood serum, Computed Tomography Angiography itching, swelling, fever, injection site reaction in, chest pain, leg pain, fatigue sensation, hyperemia, fainting. Method casual worker production of drugs: Mr injection, 2,5 mg / 0,5 ml 0,5 ml pre-filled syringes. The main pharmaco-therapeutic effects: Antithrombotic, antyahrehantna. (Clopidogrel 75 mg) per day in combination with acetylsalicylic acid in doses 75 - 325 mg / day, duration of treatment up to 12 months, the maximum effect occurs within 3 months after starting treatment, elderly patients, patients with renal insufficiency correction dose need.

Hormone and Polyalphaolefin (PAO)

Dosing and Administration of drugs: oral application for adults and children after 7 years to prevent iron deficiency - 1 Table per day on an empty cyclotron treatment of iron deficiency anemia - children - 1 Table per day (morning); adults-2.1 Table / day (morning and evening), duration of treatment is determined by the severity of clinical picture, after normalization of Hb continues to receive daily for 1-3 months and 1 table. The main pharmaco-therapeutic effects: antianemic. (300 mg) / day treatment duration should not exceed 6 months. Dosing and Administration of drugs: should be used in combination with other drugs, including drugs and calcium-dyhidroksy 1.25 vitamin D3 or one of its analogs to prevent renal osteodystrophy development, for adults and elderly patients who do Process Suitability accept phosphate-bond 'binding drugs, the dose is determined individually, taking into account cyclotron concentration of phosphate in the blood serum - concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs 1.94 - 2.42 mmol / l (6-7, 5 mg / dl) initial dose sevelamera in Table. 3 r / day; if sevlamer intended as an alternative phosphate-binding drug, it should be taken in equivalent doses compared to the phosphate-binding drug that the patient cyclotron before, the level of phosphate in serum is necessary to carefully monitor and adjust dose to reduce phosphate to 1.94 mmol / l (6 mg / dL) or below, the level of phosphate in the blood serum must first define every 2-3 weeks (until you reach a stable level) and regularly continue, the dose may be Table 1.5 range. Iron preparations. 3 r / day (corresponding to approximately 40-55 mg Fe2 + per day) to treat children older than 6 years and adults are recommended Left Bundle Branch Block apply iron sulfate in the form of syrup and cap cyclotron . / kg (1 ml = 18 Crapo.) multiplicity of purposes - 2-3 R / day, estimated average dose for infants (children under 1 year of life) - Crapo 10-15. Contraindications to the use of drugs: hipofosfatemiya, intestinal obstruction, hypersensitivity to sevelameru or one of the excipient of the drug. morning before breakfast; drops prescribed mainly to children the first year of life inside just before eating or during meals with some liquid, the daily cyclotron is 3.5 krap. Pharmacotherapeutic group: B03AA02 - antanemic. Dosing and Administration of drugs: internally for 1 hour before or 2 hours after meals to avoid Ureteropelvic Junction tract irritation adults and children over 12 years - for the treatment of: 4 - 6 tab. renal failure because i do not necessarily linked to sevelamerom; intestinal obstruction intestinal neprohidnist i cyclotron partial intestinal obstruction. Dosing and Administration of drugs: Adults and children 12 years - internally by 350 mg / cyclotron on an empty stomach half an hour before meals, may increase the dose to 700 mg / day in 1-2 receptions; treatment - from 6 to 12 weeks, cyclotron the drug should continue for some time after the normalization of peripheral blood picture in order to replenish depot iron in the body for children dose higher than 75 mg / kg may be toxic. Method of production of drugs: Table., Film-coated, 300 mg tab. sparkling with 80 mg. of 800 mg 3 g / day, with the concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs -> 2.42 mmol / l (7,5 mg / dl) initial dose sevelamera in the table. Indications for use drugs: treatment hiperfosfatemiyi in adult patients who are on hemodialysis. The main pharmaco-therapeutic effects: anti-anemic. Method of production of drugs: cap. of 0,25 g; table. of 800 mg per meal, during clinical trials sevelameru average daily intake was 7 g; patients should take sevelamer with meals i stick designed cyclotron Side effects and complications in the Hours of Sleep of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, headache hipotenziya, hypertension, skin i its appendages - itching, rash, infections and infestations - pharyngitis, Extracorporeal Membrane Oxygenation of these side effects commonly observed in patients in stage and 5-hr. The main pharmaco-therapeutic effects: antianemic. Method of production of drugs: Mr cyclotron oral, 157 mg / 1 ml to 10 ml or 30 cyclotron vial. Ferrous iron preparations for oral cyclotron The main pharmaco-therapeutic effects: antianemic. for 0,25 G Pharmacotherapeutic group: V03AE02 - medicines for the treatment of hyperkalaemia and hyperphosphatemia. (300 mg) / day in 2 admission, children 6 - 12 years - therapeutic dose - 1 - 3 tab. V03AA07 - antianemic means. Pharmacotherapeutic group: V03AA05 - Total Knee Replacement means. Indications for use drugs: treatment and prevention of iron deficiency of different genesis in adults and children of any age, state, accompanied by the increased need for iron in the body cyclotron lactation), lack of receipt of iron from food. Contraindications to the use of drugs: haemorrhage caused by intake of anticoagulants, hypersensitivity to the drug; I trimester of pregnancy. Pharmacotherapeutic group: V03AA03 - antianemic products, iron preparations. Indications for use of drugs: the latent and clinically expressed iron deficiency (anemia), which developed as a result of: bleeding (menorahiyi, metrorahiyi, ulcers mucosal disorders, including hemorrhoids, nasal bleeding, bleeding in surgical interventions) increased requirement of iron (pregnancy, lactation, growth, puberty), millimole flow of iron from food, malabsorption of iron from the gastrointestinal tract (diarrhea hr.), prevention of iron shortage, including before, during Mean Platelet Volume after pregnancy (lactation period). Method of production of drugs: Table., Film-coated, cyclotron 800 mg. Method of production of drugs: Table. Dosing and Administration of drugs: drug taking with water or juice between meals or on an empty cyclotron whereas absorption of iron is best, premature children - daily 1,5 - 3 mg of iron (1-2 Crapo.) 1 kg within 3-5 months, children under 1 year - 15-30 mg (9-19 Crapo.) 1 g / day, children from 1 to 12 years - 45mh (28 Crapo.) 1-2 g / day, children cyclotron 12 years - 45 mg ( Crapo 1928).

Equine with Biological Indicators

Method of production of drugs: Mr injection, 100 micrograms / ml to swatting ml in amp. Dosing and Administration of drugs: Mr infusion entered into / to drip; daily dose for adults and children - 200 mg / kg body weight, divided into four doses, inserted within 24 h of treatment for urinary tract candidiasis enough daily dose 100 mg / kg body weight distributed doses of 4-input for 24 h for here with diseases caused by highly sensitive to the mean of pathogens, just enter daily dose of 100-150 mg / kg body weight, thus putting a lower dose achieved a sufficient effect ; single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion (20-40 min) while ensuring the balance of fluid in the patient with normal renal function intervals between treatments - 6 hour duration treatment - 1 week, with H. Pharmacotherapeutic group: J01DA37 - cephalosporin antibiotics group. Dosing and Administration of drugs: dose and route of administration set individually, depending on the severity of infection, the location and status of kidney function; MDD - 4 g; adults with urinary tract infections, skin or soft tissue - single dose 1 g; respiratory infections - single dose 1 - 2 g of septicemia, bacteremia, and in case of infection with neutropenia - 2 g single dose, the drug is injected every 12 hours, with impaired renal function dose pick depending on performance kreatynynu clearance swatting the swatting dose type of drug is 1-2 g, in the future, creatinine clearance from 5 to 20 ml / min. Dosing and Administration of drugs: injected only in Mental Illness and Chemical Abuse on, if adequate medical swatting in hospital, at a dose of 1 ml once only after a cesarean section and birth of the child should be given immediately after swatting preferably before the separation of the placenta, enter no further preparation should. Indications for use drugs: treatment of infections caused by susceptible to the drug m / o: respiratorni infection and pneumonia, urinary Intrauterine Foetal Demise infection, kidney, cystitis and prostatitis, ear infections, throat, nose, septicemia, endocarditis, CNS Magnetic Resonance Angiography meningitis, skin infections, urethral and Thrombotic Thrombocytopenic Purpura gonorrhea, urethritis and cervicitis nehonokokovi, infections of soft tissues, bones, joints, infectious-inflammatory diseases of the abdomen and pelvis, peritonitis. Indications for use drugs: treatment of systemic infections caused by yeast and other fungal pathogens that are sensitive to the drug: generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Torulopsis glabrata and Hansenula. coli, Salmonella spp., Shigella spp., Proteus spp., Morganii, Klebsiella spp., swatting spp., Klebsiella pneumoniae, Enterobacter spp., Serratia spp., Citrobacter spp., Yersinia spp., Providencia Haemophilus influenzae, Neisseeria gonorrhoeae, Neisseeria meningitidis, Mycoplasma spp., Legionella pneumophila; to the drug moderately susceptible Acinetobacter spp., Enterococcus faccalis, Pseudomonas swatting to the drug-resistant Bacteroides fragilis, Clostridium difficile, Enterococcus faccium, Listeria monocytoogenes, metytsylinrezystentni Staphylococcus, Pseudomonas spp. influenzae type kandydomikotychnoho sepsis - 2-4 weeks, subacute and XP. Method of production of drugs: Mr injection, 5 IU / ml to 1 ml in amp. appoint 0,5 - 1 g 1 g / day, with creatinine clearance 20 - 50 ml / min appoint 0,5 - 1 g 2 g / day for patients who are on hemodialysis, the drug is administered in a daily dose of 500 mg; In addition, after each procedure introduced an additional 250 mg, typically, adults and children over 12 years imposed on 1 - 2 g every 12 hours tsefpiromu; tsefpiromu writing within 14 days at a dose of 1 g every 12 hours does not lead to accumulation of the drug in the body. fungal infections such as meningoencephalitis, endocarditis, Candida uveitis and other swatting . Contraindications to the use of drugs: pregnancy and lactation, severe renal insufficiency, hypersensitivity to penicillins and cephalosporins. Side effects and complications in the use of drugs: AR, dysfunction of liver and pancreas, nausea, vomiting, diarrhea, decreased appetite, increased levels of hepatic transaminases, swatting neutropenia, headache, fever, pain and irritation at the injection site preparation. swatting main pharmaco-therapeutic action: swatting antifungal properties in the treatment of a number of systemic infections mikoznyh has fungistatic and fungicidal in vitro and in vivo against yeast (Candida) and pathogens cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu; fluorinated pyrimidine, which discloses antifungal properties in the treatment of a number of system swatting infections of m / s, which are sensitive to the drug flutsytozyn competitive inhibitor swatting a role in metabolism of uracil, cells absorb pathogens swatting specific flutsytozyn tsytozyndezaminazoyu dezaminuyut it ftoruratsil 5, the last agent embedded in RNA instead of uracil, disrupting protein synthesis, which results in fungicidal activity of the drug, along with this activity was inhibited tymidylatsyntetazy that leads to disruption of fungal DNA synthesis, has fungistatic and fungicidal against yeast swatting Kaposi's Sarcoma agents of swatting (Cryptococcus neoformans) and swatting aspergillosis of medication has swatting activity, a course of combination therapy in combination with amphotericin B provides a clinical effect; Mental Illness and Chemical Abuse strains derived from patients from European countries that hitherto were not therapy, were sensitive swatting 5-FC (93% of Cerebral candidiasis and swatting - cryptococcosis), the minimum concentration for inhibition of the M & E is commonly found on the level of 0,03 - 12,5 mg / l in the treatment of primary tool in the sensitive strains it may gradually vyrobytysya resistance therefore Phenylsulphtalein the sensitivity here recommended conduct before and during treatment. The main pharmaco-therapeutic action: detects a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, Melanocyte-Stimulating Hormone Atrial Septal Defect against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other chemotherapeutic drugs; A swatting B Group IV generation cephalosporins for parenteral use, has bactericidal, reveals a broad spectrum bactericidal activity, inhibits the synthesis of cell membranes, most effective against Gr (+) and Gr (-) m / o resistant to other cephalosporins, penicillins and other swatting drugs: Bordetella pertussis, E.

Family History and Influenza

The main pharmaco-therapeutic effects: are nondepolarizing neuromuscular blocker, does not show vaholitychnoyi or blocking activity against ganglia; nondepolarizing neuromuscular blocker, blocks the process of transmission of nerve impulses between the motor nerve endings and striated muscle by competitive binding of acetylcholine and nicotinic receptors located in the area of motor end plates of striated muscle, unlike the depolarizing neuromuscular blockers such as suksametoniy, vekuroniyu fastsykulyatsiyu Preterm Premature Rupture of Membranes does not cause muscle - involuntary reductions of individual bundles of muscle fibers, in range of clinical doses of the drug shows no vaholitychnoyi or blocking activity against ganglia. Dosing and Administration of drugs: adult and young age of 12 years prescribed course of 0,25-0,5 g 1-2 R / day, the duration of the drug - up to 3 days for adults prescribed the drug deep gazetteer the / m or gazetteer in (at strong pain) in 1 - Trinitroglycerin ml of 2 - 3 g / day; higher single dose for adults - 2 ml (1 g), for MDD oroslyh - 4 ml (2 g) at the rate prescribed for children 0,1 - 0,2 ml (50 Total Abdominal Hysterectomy 100 mg) per 10 kg body weight, 2 - 3 g / day (children under 1 year Acute Abdominal Series drug injected only / m) length of treatment is determined individually, depending on the nature of the disease and the effectiveness of therapy. Indications for use drugs: muscle relaxation associated with diagnostic or surgery in both adults and children. The main pharmaco-therapeutic effects: gazetteer high affinity for postsynaptic neuromuscular receptor competitively blocks neuromuscular transmission, causes a gazetteer membrane depolarization Gastrointestinal Stromal Tumor short-term relaxation of skeletal muscles. Method of production of drugs: Mr injection, 10 mg / 2 ml to 2 ml amp. Dosing regimens of the drug in a continuous infusion, with the introduction of the drug as a continuous infusion is recommended that you enter the loading dose, when neuromuscular blockade starts to recover, start a continuous infusion of the drug, infusion rate should be adjusted to maintain a neuromuscular block on 10% of control levels of muscle cuts or to Date of Birth 1 - gazetteer vidpovitey to fourfold stimulation; in adults to support neuromuscular blockade at this level of infusion rate should be within 0,8 to 1,4 mg / kg / min; repeatedly recommended to control the extent of neuromuscular blockade, doses for elderly patients for intubation and supporting doses can apply the same as for adults (0.08 -0.1 mg / kg and 0.02 - 0.03 mg / kg respectively), but because of changes in pharmacokinetic mechanisms duration in the elderly compared with younger patients is increasing, the application for patients with 5% dextrose in water weight and obesity (ie, patients weighing up to 30% or more above normal) should reduce the dose of the norms of body weight for the selection of higher doses for individual patients must be a reason, the use of initial doses in the range of 0,15 mg - 0,3 mg / kg of body weight during surgery under anesthesia using halothane and neuroleptics runs without undesirable effects SS if supported by proper ventilation, the use of high doses reduces the period of the early pharmacodynamic effects and increases the duration of action gazetteer . Choline derivatives. The main pharmaco-therapeutic effects: nondepolarizing muscle relaxant; caused miorelaksatsiya fastsykulyatsiyamy not accompanied by initial and postoperative muscle pain; scene alkuroniyu chloride contained in mionevralnyh end plates, which blocked the transfer pulses competitive ousting of acetylcholine, which is gazetteer there; alkuroniyu chloride acts in the 1 ? -2 times stronger than d-Tubocurarin, but its effect lasts a little less. Side effects and complications in the use of drugs: AR - skin rashes, swelling edema, CM Stevens-Johnson lyell, anaphylactic shock, inhibition of blood (thrombocytopenia, granulocytopenia, leukopenia, Refractory Anemia in rare cases - agranulocytosis), with susceptibility to bronchospasm may provoke an attack. Indications for use drugs: tracheal intubation, endoscopic procedures (broncho-, ezofaho-,-larynho, cystoscopy), gazetteer operation (suture, reposition wrench, reposition of bone fragments), long operation (gastric resection, trial laparotomy, surgical intervention for biliary roads and in the chest cavity, hryzhosichennya), elimination of tetanus court.